The condition and the treatment

The condition and the treatment

Low- or intermediate-1 risk myelodysplastic syndromes are blood-related conditions in which not enough of a certain type of blood cell is produced. Some people with myelodysplastic syndrome have a specific genetic mutation, called an isolated deletion 5q cytogenetic abnormality. People with myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality can develop severe anaemia and need regular blood transfusions. Anaemia is a condition in which a person doesn't have enough red cells in their blood to carry oxygen around the body.

Lenalidomide (also known as Revlimid) is a drug that affects how your immune system works.

  • Information Standard